Cargando…
KSI-301: antibody biopolymer conjugate in retinal disorders
KSI-301 is a new intravitreal anti-vascular endothelial growth factor (VEGF) antibody biopolymer conjugate under investigation for the treatment of age-related macular degeneration (AMD), diabetic macular oedema (DME) and retinal vein occlusion (RVO). Preclinical and early clinical trials so far hav...
Autores principales: | Chandrasekaran, Priya R., Madanagopalan, V.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278447/ https://www.ncbi.nlm.nih.gov/pubmed/34291186 http://dx.doi.org/10.1177/25158414211027708 |
Ejemplares similares
-
Ranibizumab port delivery system in neovascular age-related macular degeneration
por: Chandrasekaran, Priya R., et al.
Publicado: (2022) -
Role of Curcumin in Retinal Diseases—A review
por: Chandrasekaran, Priya R., et al.
Publicado: (2022) -
Precision on the ksi-s measurement
por: Le Diberder, F R
Publicado: (1991) -
Observation of the decay Ksi^0_c --> Ksi- pi+ + c c in ALEPH
por: Bettarini, S, et al.
Publicado: (1994) -
Pushing the limit of the ksi_s limit to the limit
por: Jaffe, D, et al.
Publicado: (1994)